E. Haraldsen

Genetic variants of CYP19 (aromatase) and breast cancer risk

P. Lønning, A. Børresen-Dale, V. Kristensen, 2000, Oncogene.

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

P. Lønning, A. Børresen-Dale, V. Kristensen, 1999, Cancer research.

Genetic variants of CYP19 (aromatase) and breast cancer risk

P. Lønning, A. Børresen-Dale, N. Harada, 2000, Breast Cancer Research.